1. Home
  2. PASG vs ICMB Comparison

PASG vs ICMB Comparison

Compare PASG & ICMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PASG

Passage Bio Inc.

HOLD

Current Price

$5.90

Market Cap

26.0M

Sector

Health Care

ML Signal

HOLD

Logo Investcorp Credit Management BDC Inc.

ICMB

Investcorp Credit Management BDC Inc.

HOLD

Current Price

$1.86

Market Cap

30.7M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
PASG
ICMB
Founded
2017
2012
Country
United States
United States
Employees
27
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
26.0M
30.7M
IPO Year
2020
2013

Fundamental Metrics

Financial Performance
Metric
PASG
ICMB
Price
$5.90
$1.86
Analyst Decision
Buy
Analyst Count
7
0
Target Price
$14.00
N/A
AVG Volume (30 Days)
109.2K
64.7K
Earning Date
05-12-2026
05-12-2026
Dividend Yield
N/A
29.15%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$7.43
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.28
$1.29
52 Week High
$20.00
$3.12

Technical Indicators

Market Signals
Indicator
PASG
ICMB
Relative Strength Index (RSI) 36.72 46.95
Support Level N/A $1.60
Resistance Level $8.65 $3.00
Average True Range (ATR) 1.33 0.16
MACD -0.46 0.05
Stochastic Oscillator 2.54 61.93

Price Performance

Historical Comparison
PASG
ICMB

About PASG Passage Bio Inc.

Passage Bio Inc is a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases. Their primary focus is the development and advancement of cutting-edge, one-time gene therapies designed to target critical underlying pathologies in these conditions. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target the critical underlying pathology of neurodegenerative diseases. The pipeline having PBFT02.

About ICMB Investcorp Credit Management BDC Inc.

Investcorp Credit Management BDC Inc is an externally managed, non-diversified closed-end management investment firm that has elected to be regulated as a business development company (BDC). The investment objective of the company is to maximize total return to stockholders in the form of current income and capital appreciation by investing in debt and related equity of privately held lower middle-market companies. The company principally invests in the debt of middle-market companies, which it defines as those companies that have an enterprise value.

Share on Social Networks: